Eric Salzman's most recent trade in Leonardo DRS Inc. was a trade of 3,556 Restricted Stock Unit done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Leonardo DRS Inc. | Eric C. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 3,556 | 3,556 | - | - | Restricted Stock Unit | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 6,438 | 0 | - | - | Restricted Stock Unit | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 6,438 | 16,223 | - | 0 | Common Stock | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Sale of securities on an exchange or to another person at price $ 33.53 per share. | 12 Feb 2025 | 3,477 | 9,785 | - | 33.5 | 116,584 | Common Stock |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Sale of securities on an exchange or to another person at price $ 34.59 per share. | 11 Feb 2025 | 3,477 | 13,262 | - | 34.6 | 120,269 | Common Stock |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 9,785 | 0 | - | - | Restricted Stock Unit | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 9,785 | 16,739 | - | 0 | Common Stock | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 6,438 | 6,438 | - | - | Restricted Stock Unit | |
| Safeguard Scientifics, Inc. | Eric Salzman C. | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 125,000 | 415,584 (2%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Salzman C. Eric | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.03 per share. | 15 Dec 2023 | 63,614 | 351,970 (1%) | 0% | 1.0 | 65,643 | Common Stock |
| Safeguard Scientifics, Inc. | Salzman Eric C. | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.03 per share. | 15 Dec 2023 | 5,244 | 346,726 (1%) | 0% | 1.0 | 5,411 | Common Stock |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.23 per share. | 15 Aug 2023 | 5,297 | 306,498 (1%) | 0% | 1.2 | 6,515 | Common Stock |
| 8X8 Inc. | Eric C. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2023 | 35,000 | 165,094 (0%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.43 per share. | 17 Jul 2023 | 5,297 | 311,795 (1%) | 0% | 1.4 | 7,601 | Common Stock |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 15 Jun 2023 | 4,854 | 317,092 (1%) | 0% | 1.6 | 7,895 | Common Stock |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 9,785 | 9,785 | - | - | Restricted Stock Unit | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 6,954 | 0 | - | - | Restricted Stock Unit | |
| Leonardo DRS Inc. | Eric C. Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 6,954 | 6,954 | - | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.76 per share. | 15 May 2023 | 5,297 | 321,946 (1%) | 0% | 1.8 | 9,323 | Common Stock |
| Movella Holdings Inc - Ord... | Eric C. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 71,428 | 71,428 | - | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.88 per share. | 15 Apr 2023 | 4,762 | 327,243 (1%) | 0% | 1.9 | 8,976 | common stock |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share. | 15 Mar 2023 | 5,297 | 332,005 (1%) | 0% | 1.9 | 9,879 | common stock |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.19 per share. | 15 Feb 2023 | 5,296 | 337,302 (1%) | 0% | 3.2 | 16,868 | Common Stock |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 125,000 | 348,494 (1%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 64,000 | 257,784 (1%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 17 Jan 2023 | 34,290 | 223,494 (1%) | 0% | 3.1 | 107,156 | Common Stock |
| Safeguard Scientifics, Inc. | Eric C. Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 17 Jan 2023 | 5,896 | 342,598 (1%) | 0% | 3.1 | 18,425 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Nov 2022 | 2,542 | 196,326 (0%) | 0% | 3.7 | 9,394 | common stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 4.24 per share. | 01 Nov 2022 | 34,600 | 195,494 (0%) | 0% | 4.2 | 146,856 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 01 Nov 2022 | 25,000 | 155,094 (0%) | 0% | 4.2 | 105,028 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 4.19 per share. | 01 Nov 2022 | 15,400 | 180,094 (0%) | 0% | 4.2 | 64,532 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 4.09 per share. | 01 Nov 2022 | 14,028 | 130,094 (0%) | 0% | 4.1 | 57,390 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 4.09 per share. | 01 Nov 2022 | 10,972 | 144,122 (0%) | 0% | 4.1 | 44,889 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Oct 2022 | 2,542 | 198,868 (0%) | 0% | 3.7 | 9,418 | common stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.03 per share. | 15 Sep 2022 | 2,542 | 201,410 (0%) | 0% | 4.0 | 10,251 | common stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. | 15 Aug 2022 | 2,542 | 203,952 (0%) | 0% | 4.1 | 10,498 | common stock |
| 8X8 Inc. | Eric Salzman | Director | Grant, award, or other acquisition of securities at price $ 4.55 per share. | 15 Jul 2022 | 38,461 | 230,094 (0%) | 0% | 4.6 | 174,998 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.86 per share. | 15 Jul 2022 | 2,542 | 206,494 (0%) | 0% | 3.9 | 9,812 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 15 Jun 2022 | 2,542 | 209,036 (1%) | 0% | 3.7 | 9,426 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.59 per share. | 15 May 2022 | 2,542 | 211,578 (1%) | 0% | 3.6 | 9,138 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.93 per share. | 15 Apr 2022 | 2,331 | 214,120 (1%) | 0% | 4.9 | 11,503 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.97 per share. | 15 Mar 2022 | 2,542 | 216,451 (1%) | 0% | 5.0 | 12,634 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 30,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| 8X8 Inc. | Eric Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 22 Feb 2022 | 30,000 | 211,062 (0%) | 0% | 4.3 | 129,600 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 12.85 per share. | 22 Feb 2022 | 7,500 | 196,062 (0%) | 0% | 12.9 | 96,375 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 12.86 per share. | 22 Feb 2022 | 7,500 | 203,562 (0%) | 0% | 12.9 | 96,450 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 12.83 per share. | 22 Feb 2022 | 4,429 | 191,633 (0%) | 0% | 12.8 | 56,824 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2022 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| 8X8 Inc. | Eric Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 17 Feb 2022 | 30,000 | 200,090 (0%) | 0% | 4.3 | 129,600 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Sale of securities on an exchange or to another person at price $ 13.94 per share. | 17 Feb 2022 | 19,028 | 181,062 (0%) | 0% | 13.9 | 265,273 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.21 per share. | 15 Feb 2022 | 1,802 | 218,993 (1%) | 0% | 6.2 | 11,193 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2022 | 85,000 | 207,194 (1%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2022 | 60,000 | 223,324 (1%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.10 per share. | 17 Jan 2022 | 43,870 | 163,324 (0%) | 0% | 7.1 | 311,477 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.10 per share. | 17 Jan 2022 | 2,529 | 220,795 (1%) | 0% | 7.1 | 17,956 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Grant, award, or other acquisition of securities at price $ 25.57 per share. | 05 Aug 2021 | 6,843 | 170,090 (0%) | 0% | 25.6 | 174,976 | Common Stock |
| 8X8 Inc. | Eric Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 15,000 | 60,000 | - | - | Employee Stock Option (right to buy) | |
| 8X8 Inc. | Eric Salzman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.32 per share. | 11 May 2021 | 15,000 | 163,247 (0%) | 0% | 4.3 | 64,800 | Common Stock |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Oct 2020 | 17,000 | 122,194 (0%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 75,000 | 105,194 (0%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 3,333 | 0 | - | - | Restricted Stock Units | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 3,333 | 30,194 (0%) | 0% | - | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 3,334 | 3,333 | - | - | Restricted Stock Units | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 3,334 | 26,861 (0%) | 0% | - | Common Stock | |
| 8X8 Inc. | Eric Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2020 | 11,146 | 148,247 (0%) | 0% | 0 | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 3,333 | 23,527 (0%) | 0% | - | Common Stock | |
| Safeguard Scientifics, Inc. | Eric Salzman | Chief Restructuring Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 3,333 | 6,667 | - | - | Restricted Stock Units |